PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12139894

[A combined neonatal hearing screening protocol].

A Almenar Latorre·M C Tapia Toca·C Fernández Pérez·M Moro Serrano
View original source ↗Export metadata ↓

Abstract

OBJECTIVE: To analyze a neonatal hearing screening protocol with transient evoked otoacoustic emissions (OAE) and auditory brainstem response (ABR). PATIENTS AND METHODS: We studied 1,532 newborns with a protocol using transient evoked otoacoustic emissions and auditory brainstem response. We also evaluated auditory development until twelve months of age with quarterly questionnaires. RESULTS: A total of 1,485 (97 %) newborns had normal OAE, 185 (12 %) were referred for ABR exploration and only 11 (0.7 %) were referred to the otorhinolaryngology service for auditory study and diagnosis. Four neonates had auditory disjunction. No false negatives were detected in the follow-up. CONCLUSIONS: This hearing screening protocol with OEA and ABR is useful for detecting hearing loss in neonates. The prevalence of hearing loss in this study was 2.6 % of live newborns.

Explore related subjects

Evoked Potentials, Auditory, Brain StemFemaleHearing DisordersHumansInfantInfant, NewbornMaleNeonatal ScreeningOtoacoustic Emissions, SpontaneousEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Almenar Latorre, M C Tapia Toca, C Fernández Pérez, M Moro Serrano. 2002. [A combined neonatal hearing screening protocol].. https://pubmed.ncbi.nlm.nih.gov/12139894/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Universal newborn hearing screening in Mexico: results of the first 2 years.

OBJECTIVE: The purpose of this study is to present the results of the first 2 years of universal newborn hearing screening and the prevalence of congenital hearing loss in Monterrey, Mexico. MATERIALS AND METHODS: We performed a descriptive study of the first 2 years after starting of the newborn screening program in a private hospital in Mexico. The program is organized into levels. We using for initial evaluation an automated auditory brainstem response (AABR). If the test was positive, the audiologist conducted and auditory brainstem response (ABR) test and other specialized testing was performed. Babies with hearing impairment were referred for early intervention. RESULTS: A total of 3066 newborns were screened (99.9%). The prevalence of sensorineural and bilateral hearing loss was of 0.65/1000 newborns. Seventy-three neonates (2.37%) had a risk factor for hearing impairment. A total of 0.22% (n=7) of those studied were referred for ABR testing. Of the patients referred to the audiologist, 100% were seen. The positive predictive value for sensorineural hearing loss was 71.4% (95% CI 30.2-94.8) and the false positive rate was 0.065%. Of the subjects screened, 100% were diagnosed before the age of 3 months, but all babies began treatment after the age of 6 months. No cochlear implants were indicated. CONCLUSION: This is the first report of a universal hearing screening program in Mexico. Even though this study had a reduced sample, the findings of hearing loss rate in this study are similar to the results found in other countries.

Evoked Potentials, Auditory, Brain Stem↗
PubMed2006

Auditory neuropathy/auditory dys-synchrony detected by universal newborn hearing screening.

The implementation of neonatal hearing screening has enabled early detection and intervention in hearing loss. The use of otoacoustic emissions (OAE) and auditory brainstem response testing in universal screening has led to the recognition of this recently described disorder called auditory neuropathy/auditory dys-synchrony (AN/AD). This diagnosis indicates that the infant has significant hearing loss despite having normal outer hair cells in the cochlea. We reviewed the characteristics and natural history of nine infants detected to have AN/AD from universal newborn hearing screening in a national pediatric hospital. Fifty-two cases of hearing loss were detected from 14,807 consecutively screened cases. Of the 52 cases, 9 had electrophysiological test results consistent with AN/AD. They include both premature infants who had major neonatal complications and term infants with no perinatal complications. Six cases had bilateral and three cases had unilateral findings. We suggest that AN/AD can occur in low-risk infants and hence screening of high-risk cases alone is insufficient. Our findings are discussed with reference to the current literature.

Evoked Potentials, Auditory, Brain Stem↗